Clinical Trial

Urdu Translation of Revised High-Level Mobility Assessment Tool (HiMAT) in Healthy Children

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 23, 2025 (before its estimated June 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
The ability to move with ease is labelled as mobility. Limitations in mobility are frequent, recovery of these skills is crucial for physical performance which gives children valuable social possibilities and has long-term advantages for their physical and mental health. The high-level mobility assessment tool (HiMAT) is a unidimensional performance to measure the degree of high-level mobility in traumatic brain injury patients. The revised HiMAT has been utilised recently in paediatric populations to assess clinical trial outcomes and measure high-level motor skills. Urdu translation of revised HiMAT will be executed by using forward backwards translation method. Two bilingual translators fluent in both Urdu and English languages will facilitate the researcher in the translation of the tool. This final translated version will be then tested for validity and reliability on all participants of the study. The psychometric properties of the tool will be assessed including reliability, internal consistency, and item discrimination.
Trial Details
NCT Number NCT06986720
Lead Sponsor Riphah International University
Conditions Healthy Children
Enrollment 80 participants
Start Date 2025-05-12
Primary Completion 2025-06-28 (estimated)
Study Completion 2025-07-16 (estimated)
Updated on ClinicalTrials.gov 2025-05-23